Top

Published in:

Open Access 01-12-2018 | Research article

Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015

Authors: Dao Nguyen Vinh, Dang Thi Minh Ha, Nguyen Thi Hanh, Guy Thwaites, Maciej F. Boni, Hannah E. Clapham, Nguyen Thuy Thuong Thuong

Published in: BMC Infectious Diseases | Issue 1/2018

Abstract

Background

The depletion of CD4 cell is the underlying reason for TB hyper-susceptibility among people with HIV. Consequently, the trend of TB dynamics is usually hidden by the HIV outbreak.

Methods

Here, we aim to evaluate the trend of TB dynamics quantitatively by a simple mathematical model using the known prevalence of hyper-susceptible individuals in the population. In order to estimate the parameters governing transmission we fit this model in a maximum likelihood framework to both reported TB cases and data from samples tested with Interferon Gamma Assay from Ho Chi Minh City - a city with high TB transmission and strong synchronization between HIV/AIDS and TB dynamics.

Results

Our results show that TB transmission in HCMC has been declining among people without HIV; we estimate a 18% (95% CI: 9–25%) decline in the transmission parameter between 1996 and 2015. Furthermore, we show that co-infected patients have limited contribution to the transmission process. For hyper-susceptible individuals, our model suggests that the risk of a new active TB infection occurring is significantly higher than the risk of relapsed active TB, while this is not the case for people without hyper-susceptibility.

Conclusions

The increase of TB notifications in Ho Chi Minh City from 1996 to 2008 is evitable when, as occurred, the number of hyper-susceptible individuals increased faster than the decrease of TB transmission rate. The sharp decrease in TB notifications observed in this city from 2008 to 2015 is the combined result of the decrease of TB transmission rate and the decrease of hyper-susceptible individuals in the population. For hyper-susceptible individuals, we propose that the reason for the reduced relapsed active TB risk is HIV treatment delay. According to HIV treatment guidelines issued by Vietnam’s Ministry of Health, hyper-susceptible individuals usually have to wait until their CD4 cell count falls under 350 cells/μl to start ART. Once patients begin ART, they will remain on ART for the rest of their life and thus have greater protection against relapses of TB. We therefore hypothesize that the delay in using ART imposes considerable TB burden on HCMC despite the declining transmission process.

Available only for authorised users

Rampatige R, Gilks CF. Autopsies and better data on causes of death in Africa. Lancet Infect Dis [internet]. 2015;15:492–4 Elsevier Ltd . Available from: http://linkinghub.elsevier.com/retrieve/pii/S1473309915700964.CrossRef

Ngo AD, Rao C, Hoa NP, Adair T, Chuc NTK. Mortality patterns in Vietnam, 2006: findings from a national verbal autopsy survey. BMC Res Notes [Internet]. 2010;3:78 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2851717&tool=pmcentrez&rendertype=abstract.CrossRef

World Health Organization. Treatment of tuberculosis guidelines. 4th. 2009.

World Health Organization. Treatment of tuberculosis: Guidelines for national programmes. 2003.

Huong NT, Duong BD, Co N V., Quy HT, Tung LB, Bosman M, et al. Establishment and development of the National Tuberculosis Control Programme in Vietnam. Int J Tuberc Lung Dis. [internet]. 2005;9:151–156. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15732733.

World Health Organization. Global Tuberculosis Report - 2011. 2011;

World Health Organization. Global Tuberculosis Report - 2015; 2015. p. 1.

Nguyen TA, Oosterhoff P, Hardon A, Tran HN, Coutinho RA, Wright P. A hidden HIV epidemic among women in Vietnam. BMC Public Health [Internet]. 2008;8:37. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2248180&tool=pmcentrez&rendertype=abstract.

Vietnam Ministry of Health. Annual Report of HIV Epidemic - 2015. 2015;

10.

Bacaër N, Ouifki R, Pretorius C, Wood R, Williams B. Modeling the joint epidemics of TB and HIV in a south African township. J Math Biol [Internet]. 2008;57:557–93 Available from: http://link.springer.com/10.1007/s00285-008-0177-z.CrossRef

11.

Williams BG, Gouws E, Somse P, Mmelesi M, Lwamba C, Chikoko T, et al. Epidemiological trends for HIV in southern Africa: implications for reaching the elimination targets. Curr HIV/AIDS Rep. 2015;12:196–206.CrossRef

12.

Pretorius C, Menzies NA, Chindelevitch L, Cohen T, Cori A, Eaton JW, et al. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS [Internet]. 2014;28 Suppl 1:S25–S34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24468944 CrossRef

13.

Kunkel A, Crawford FW, Shepherd J, Cohen T. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS [Internet]. 2016;30:2715–23 Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089846/pdf/nihms814768.pdf.CrossRef

14.

Heymann SJ. Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in africa. Trans R Soc Trop Med Hyg. 1993;87:406–11.CrossRef

15.

Williams BG, Gupta S, Wollmers M, Granich R. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study. Lancet Public Heal [Internet]. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license; 2017;2:e223–e230. Available from: https://doi.org/10.1016/S2468-2667(17)30066-X.CrossRef

16.

Cain K, Kanara N, Laserson K, Vannarith C, Sameourn K, Samnang K, et al. The epidemiology if HIV associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis. 2007;11:1008–13.PubMed

17.

Blower SM, Mclean AR, Porco TC, Small PM, Hopewell PC, Sanchez MA, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med [Internet]. 1995;1:815–821. Available from: http://www.nature.com/doifinder/10.1038/nm0895-815.CrossRef

18.

Gomes MGM, Franco AO, Gomes MC, Medley GF. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc R Soc B Biol Sci [Internet]. 2004;271:617–23 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1691632&tool=pmcentrez&rendertype=abstract.CrossRef

19.

Ahmadin, Fatmawati. Mathematical modeling of drug resistance in tuberculosis transmission and optimal control treatment. Appl Math Sci. [Internet]. 2014;8:4547–4559. Available from: http://www.m-hikari.com/ams/ams-2014/ams-89-92-2014/fatmawatiAMS89-92-2014.pdf.CrossRef

20.

Rodrigues P, Gomes MGM, Rebelo C. Drug resistance in tuberculosis—a reinfection model. Theor Popul Biol [Internet]. 2007;71:196–212 Available from: https://www.sciencedirect.com/science/article/pii/S0040580906001316?via%3Dihub.CrossRef

21.

Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect [Internet]. 1997;119:S0950268897007917. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808840/pdf/9363017.pdf.

22.

Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Dye C, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA. [Internet]. 2009;106:13980–13985. Available from: http://www.pnas.org/content/pnas/106/33/13980.full.pdf.CrossRef

23.

Bhunu CP, Garira W, Mukandavire Z. Modeling HIV/AIDS and tuberculosis coinfection. Bull Math Biol [Internet]. 2009;71:1745–80 Available from: http://link.springer.com/10.1007/s11538-009-9423-9.CrossRef

24.

Bolarin G. Omatola IU. A Mathematical analysis of HIV/TB co-infection model. Proc. 2006 winter Simul. Conf. 2006. p. 459–465.

25.

Naresh R, Tripathi A, Omar S. Modelling the spread of AIDS epidemic with vertical transmission. Appl Math Comput [Internet]. 2006;178:262–72 Available from: http://linkinghub.elsevier.com/retrieve/pii/S0096300305009720.CrossRef

26.

Roeger L-IW, Feng Z, Castillo-Chavez C. Modeling TB and HIV co-infections. Math Biosci Eng [Internet]. 2009;6:815–837. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19835430

27.

Wang X, Yang J, Zhang F. Dynamic of a TB-HIV coinfection epidemic model with latent age. J Appl Math [Internet]. 2013;2013:1–13 Available from: http://www.hindawi.com/journals/jam/2013/429567/.

28.

Yaesoubi R, Cohen T. Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics. Proc Natl Acad Sci [Internet]. 2013;110:9457–62 Available from: http://www.pnas.org/lookup/doi/10.1073/pnas.1218770110.CrossRef

29.

Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis [Internet]. 1993;148:1292–7 Available from: http://www.atsjournals.org/doi/abs/10.1164/ajrccm/148.5.1292.CrossRef

30.

Gupta RK, Lawn SD, Bekker L-G, Caldwell J, Kaplan R, Wood R. Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. Int J Tuberc Lung Dis [Internet]. 2013;17:1014–22 Available from: http://openurl.ingenta.com/content/xref?genre=article&issn=1027-3719&volume=17&issue=8&spage=1014.CrossRef

31.

Ozcaglar C, Shabbeer A, Vandenberg SL, Yener B, Bennett KP. Epidemiological models of Mycobacterium tuberculosis complex infections. Math Biosci. 2012;236:77–96.CrossRef

32.

General Statistics Office of Vietnam. Population and Employment Statistics [Internet]. Stat Handb. Vietnam. 2016 [cited 2017 Mar 13]. Available from: https://gso.gov.vn/default_en.aspx?tabid=774

33.

Vietnam Authority of HIV/ AIDS Control. An Annual Update on The HIV Epidemic in Vietnam. 2014;

34.

Blount RJ, Tran B, Jarlsberg LG, Phan H, Thanh Hoang V, Nguyen NV, et al. Childhood tuberculosis in northern Viet Nam: a review of 103 cases. PLoS One. 2014;9.CrossRef

35.

Immunotec O. T-Spot TB Package Insert - For In Vitro Diagnostic Use Only; 2003. p. 2.

36.

Nelder JA, Mead R. A simplex method for function minimization. Comput J [Internet]. 1965;7:308–13 Available from: https://pdfs.semanticscholar.org/da24/280dfcd767524fb1a1702f50f388ca0d4082.pdf.CrossRef

37.

Gelman A, Carlin J, Stern H, Dunson D, Vehtari A, Rubin D. Bayesian data analysis, third edition (Chapman & Hall/CRC texts in statistical science). Third edit. London: Chapman and Hall/CRC; 2014.

38.

Garfein RS, Laniado-laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, et al. Latent Tuberculosis among Persons at Risk for Infection with HIV. Emerg Infect Dis. 2010;16:757–63.CrossRef

39.

Oxlade O, Murray M. Tuberculosis and poverty: why are the poor at greater risk in India? PLoS One [Internet]. 2012; 7: e47533. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23185241

40.

Gillies P, Tolley K, Wolstenholme J. Is AIDS a disease of poverty? AIDS Care [Internet]. 1996;8:351–64 Available from: https://www.ncbi.nlm.nih.gov/pubmed/8827126.CrossRef

41.

Muniyandi M, Ramachandran R. Socioeconomic inequalities of tuberculosis in India. Expert Opin Pharmacother [Internet]. 2008;9:1623–8 Available from: http://www.tandfonline.com/doi/full/10.1517/14656566.9.10.1623.CrossRef

42.

Grange J, Zumla A. Tuberculosis and the poverty-disease cycle. J R Soc Med [Internet]. 1999;92:105–107. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297096/pdf/jrsocmed00011-0007.pdf.CrossRef

43.

Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in south African gold miners. J Infect Dis [Internet]. 2005;191:150–158. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15609223 CrossRef

44.

Ellis PK, Martin WJ, Dodd PJ. CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis. PeerJ [Internet]. 2017;5:e4165. Available from: https://peerj.com/articles/4165 CrossRef

45.

Nanoo A, Izu A, Ismail NA, Ihekweazu C, Abubakar I, Mametja D, et al. Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis. Lancet Infect Dis. [Internet]. Elsevier Ltd. 2015;15:1066–76 Available from: http://linkinghub.elsevier.com/retrieve/pii/S1473309915001474.CrossRef

46.

Van Rie A, Westreich D, Sanne IM. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011;56:349–55.CrossRef

47.

Kaplan R, Caldwell J, Middelkoop K, Bekker L-G, Wood R. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009–2011). JAIDS J Acquir Immune Defic Syndr [Internet]. 2014;66:487–494. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24820105.CrossRef

48.

Wood R, Johnstone-Robertson S, Uys P, Hargrove J, Middelkoop K, Lawn SD, et al. Tuberculosis transmission to young children in a south African community: modeling household and community infection risks. Clin Infect Dis [Internet]. 2010;51:401–8 Available from: http://cid.oxfordjournals.org/lookup/doi/10.1086/655129.CrossRef

49.

Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med [Internet]. 2004;10:1117–1121. Available from: http://www.nature.com/doifinder/10.1038/nm1110 CrossRef

50.

Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJD. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One [Internet]. 2011;6:e17601. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21483732 CrossRef

51.

World Health Organization. Global Tuberculosis Report - 2012. 2012;

52.

Worldbank. GDP per capita (current US$) | Data [Internet]. [cited 2018 Apr 19]. Available from: https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=VN

53.

Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis [Internet]. 2012;54:784–91 Available from: https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cir951.CrossRef

54.

Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR. Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup. Am J Epidemiol [Internet]. 2014;179:216–25 Available from: http://aje.oxfordjournals.org/cgi/doi/10.1093/aje/kwt246.CrossRef

Title: Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015
Authors: Dao Nguyen Vinh
Dang Thi Minh Ha
Nguyen Thi Hanh
Guy Thwaites
Maciej F. Boni
Hannah E. Clapham
Nguyen Thuy Thuong Thuong
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI: https://doi.org/10.1186/s12879-018-3383-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2018

Landscape and rodent community composition are associated with risk of hemorrhagic fever with renal syndrome in two cities in China, 2006–2013

Genetic characterization of norovirus GII.4 variants circulating in Canada using a metagenomic technique

Impact of microbial Aetiology on mortality in severe community-acquired pneumonia

Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study

Human papillomavirus infection & anal cytological abnormalities in HIV-positive men in eastern India

Plasmodium knowlesi infection in a returning German traveller from Thailand: a case report on an emerging malaria pathogen in a popular low-risk travel destination

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page